Anti-Estrogen Steroids CAS 129453-61-8 Faslodex for Breast Cancer
-
Post Date:
Mar 23,2017
-
Expiry Date:
Mar 23,2018
-
Detailed Description:
Cas No. :129453-61-8
Quantity: 1000Kilograms
Specs:white powder
Price:10 USD Kilograms
Payment Method: T/T,Western Union,Moneygram,
Formestane description
Fulvestrant Acetate (trade name Faslodex, by Astra Zeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a completeestrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.
Formestane basic info.
Fulvestrant (Steroids)
CAS:129453-61-8
Synonyms: FASLODEX
Chemical Name:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
Molecular Fomular:C32H47F5O3S
Molecular Weight:606.77
Density:1.201 g/cm3
Melting Point:104-106℃
Boiling Point:674.8 °C at 760 mmHg
Appearance:white powder
Usage:Antineoplastic (hormonal)
Storage:2-8°C
-
CAS Registry Number:
129453-61-8
-
Synonyms:
;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;(17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;Faslodex;
-
Molecular Formula:
C32H47F5O3S
-
Molecular Weight:
606.7708
-
Molecular Structure:
-
Company:
China yuancheng technoloty wuhan branch ltd.
[ China ]
-
Contact:
Kathelin
-
Tel:
86-27-6888669
-
Fax:
-
Email:
kathelin@chembj.com
Inquiry